Sirt2 protects mice against both aging-related and Ang II-induced cardiac hypertrophy through activating AMPK by deacetylating LKB1, indicating that Sirt2 may be a potential target for the treatment of cardiac hypertrophy (36). Here, STK11 is linked to cardiac hypertrophy.